Clinical Trial Update: Acute Coronary Syndrome in Patients With COVID-19

View source ↗

Summary

A completed clinical trial from the Bulgarian Cardiac Institute evaluating acute coronary syndrome in patients with COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: Bulgarian Cardiac Institute | Conditions: Myocardial Infarction, Acute Coronary Syndrome | Status: COMPLETED